Searched for
VACCINE SAFETY STUDY
Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- ICMR draws flak from experts over call for BHU study retractionUniversal Health Organisation (UHO) criticizes ICMR for questioning BHU researchers over Covaxin study, calling for academic freedom and da...
- Covaxin demonstrated excellent safety record during studies: Bharat BiotechBharat Biotech asserted the safety of its Covid-19 vaccine, Covaxin, citing various studies published in peer-reviewed journals. This state...
- Covaxin proven safe for children of 2-18 years age group in phase III study: Bharat BiotechThe clinical trial conducted in the pediatric population has shown safety, less reactogenic, and robust immunogenicity. The data was submit...
- RDIF says early results of 'mix & match' of Sputnik Light, AstraZeneca jab found to be safeAstraZeneca COVID vaccine is the same as Covishield which is used in India and several other countries.
- NIE plans study on booster for those with comorbiditiesThe Indian Council of Medical Research's NIE has proposed to conduct phase-2 safety and immunogenicity study specifically on people with co...
- Bharat Biotech’s Covaxin has 77.8% efficacy rate, presents no safety concerns: Lancet studyCovaxin “induces a robust antibody response" two weeks after two doses are given, it said. “Covaxin’s Phase 3 efficacy results have been pe...
- Mix of Covishield, Covaxin yields better results, finds ICMR StudyThe study titled ‘Serendipitous COVID-19 Vaccine-Mix in Uttar Pradesh, India: Safety and Immunogenicity Assessment of a Heterologous Regime...
- No sign of Pfizer, Moderna Covid vaccines in breast milk: StudyThe study, published in the journal JAMA Pediatrics, offers the first direct data of vaccine safety during breastfeeding and could allay co...
- Bharat Biotech shares elaborate data of all research studies of CovaxinCovaxin, a whole-virion inactivated coronavirus vaccine, is the first and only product to have published any data from human clinical trial...
- Covaxin phase 3 full trial data to be made public in July: Bharat BiotechThe indigenous whole virion inactivated SARS-Cov-2 virus vaccine company has also said that Covaxin will even undergo the phase 4 trials to...
- Gennova set to kick off trials for India’s first mRNA vaccineCurrently, the two mRNA vaccines that are under use for Covid-19 are by US drug makers Pfizer and Moderna and have shown to have over 90% e...
- New study says pregnant women getting Covid vaccince can protect their unborn babiesAntibodies were detected in newborn after mothers were given vaccine in the third trimester.
- Dr Reddy’s Laboratories gets approval for phase 3 trials of Sputnik V Covid vaccine“The Indian clinical trial being conducted by Dr Reddy’s and RDIF is an adaptive design phase 2/3 trial. It is a bridging study to the larg...
- Do high-risk groups get priority over others? Emergency use of a Covid-19 vaccine explainedDuring a health crisis, the FDA can loosen its normal scientific standards.
- Bharat Biotech to start phase III trials for its indigenously developed COVID-19 vaccine“We are planning to initiate a large phase 3 multicentre study to evaluate the efficacy and safety of the vaccine,” Bharat Biotech said in ...
- DGCI directs Serum Institute to suspend any new recruitment in phase 2, 3 COVID-19 vaccine clinical trialsOn 9 September ANI first reported that DCGI issued a show-cause notice to Serum Institute for not pausing the ongoing clinical trial of the...
- Oxford Covid-19 vaccine trial paused after unexplained illness, says AstraZenecaLate last month, AstraZeneca began recruiting 30,000 people in the US for its largest study of the vaccine. It also is testing the vaccine,...
- Government to conduct major study on Pentavalent vaccine safetyIn the wake of 21 infants dying after receiving Pentavalent vaccine in the country, government will conduct a major study to ascertain its ...
Load More
